Research Programme · Bacterial AMR & One Health
Vaccine Research
Preventing bacterial infections means fewer antibiotics and less resistance. We study vaccine targets against priority antimicrobial-resistant bacteria.
Why it matters
Vaccines prevent bacterial infections before antibiotics are needed, which slows the spread of resistance. Vaccine research on priority resistant bacteria complements our work on surveillance, diagnostics and treatment.
Our goal
Contribute to the development and evaluation of vaccine strategies against priority antimicrobial-resistant bacteria, within a One Health approach.
Specific objectives
What the programme sets out to achieve.
Identify priority antigens and vaccine targets in resistant bacterial pathogens.
Study immune responses to priority bacteria in humans and animals.
Assess how vaccine strategies could reduce antibiotic use and antimicrobial resistance.
Support the integration of results into prevention strategies.
Main activities
- Genomic and immunological analyses to identify vaccine targets
- Preclinical and experimental studies
- Modelling of vaccine impact on infection dynamics
- Collaboration with academic and institutional partners
Milestones ahead
Deliverables planned under the institute’s strategic plan.
- Identified and prioritised vaccine targets
- Experimental and preclinical results
- Scientific recommendations for prevention policies